NextGen Biomed 2026, London's leading biologics and immunotherapy R&D conference, brings together 1,000+ senior scientists, clinicians, and industry leaders across two days of cutting-edge science, strategic networking, and commercial opportunity.

Whether you're advancing biologics discovery, optimising ADC pipelines, exploring AI-driven drug design, or navigating the translational gap from bench to clinic, NextGen Biomed is built around the problems you're working through right now.

Who is NextGen Biomed for?

Researchers, clinicians, and industry scientists working across biologics, immunotherapy, antibody engineering, peptides, oligonucleotides, and AI-driven drug discovery. From early-career scientists to C-suite decision-makers, the programme is designed to deliver value at every level of seniority.

What will I get from attending?

200+ sessions across four concurrent programmes, including keynotes, panels, workshops, and roundtables covering the full R&D value chain. The event is CPD accredited, attend across both days and earn 14 hours of verified CPD credits and a CPD certificate. Use the personalised agenda tool to map your two days in advance and arrive knowing exactly where to be.

Personalised agenda tool: https://nextgen-biomed.exhibitly.ai/en?button_type=menu

Where and when?

24–25 March 2026 | QEII Centre, London, UK. A Workshop Day on 23 March is also available for hands-on, skills-focused learning.

Is attendance free?

Registration is free for researchers and academics. Solution provider passes are available from £499 + VAT.